BRD4 and ovarian cancer: A study by Li et al. found that treatment of macrophages cultured in ovarian cancer cell line–conditioned media with the BRD4 inhibitor AZD5153 reversed their M2-like TAM phenotype with reduced expression of ARG1, MRC1, and IL10 (15).